Amicus Therapeutics
FOLD
#3550
Rank
โ‚ฌ2.93 B
Marketcap
9,83ย โ‚ฌ
Share price
-1.14%
Change (1 day)
2.39%
Change (1 year)

Operating Margin for Amicus Therapeutics (FOLD)

Operating Margin as of November 2024 (TTM): -21.91%

According to Amicus Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -21.91%. At the end of 2023 the company had an Operating Margin of -25.03%.

Operating Margin history for Amicus Therapeutics from 2008 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-25.03%-59.79%
2022-62.24%-9.05%
2021-68.44%-29.1%
2020-96.53%-47.81%
2019-184.94%-48.34%
2018-358.03%-69.38%
2017-1,169.46%-70.77%
2016-4,001.27%
2014-5,600.90%-67.78%
2013-17,382.64%6061.45%
2012-282.12%26.26%
2011-223.44%-96.31%
2010-6,053.69%61849.95%
2009-9.77%-96.26%
2008-261.49%-89.82%
2007-2,567.54%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
13.58%-161.98%๐Ÿ‡บ๐Ÿ‡ธ USA
14.22%-164.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-179.86% 720.90%๐Ÿ‡บ๐Ÿ‡ธ USA
10.36%-147.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
-5,550.86% 25,234.82%๐Ÿ‡บ๐Ÿ‡ธ USA
45.06%-305.66%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.